Treatment of Dark Spots (Hyperpigmentation)
First-Line Treatment Approach
For post-inflammatory hyperpigmentation (PIH) and melasma, start with topical hydroquinone 4% combined with tretinoin 0.05% and a topical corticosteroid (triple combination therapy), applied nightly with strict daily broad-spectrum sunscreen use. 1, 2
Evidence-Based Treatment Algorithm
Initial Therapy (Weeks 0-12)
Topical Regimen:
- Triple combination cream (Tri-Luma®: fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) is FDA-approved specifically for melasma and represents the gold standard first-line treatment 1
- Apply once daily at bedtime to affected areas only 3
- Wait 20-30 minutes after washing face before application to minimize irritation 3
- Use a mild, non-medicated soap and avoid harsh scrubbing 3
Mandatory Photoprotection:
- Apply broad-spectrum sunscreen every morning, as UV exposure is the primary cause of recurrence 1, 2, 4
- Use non-comedogenic moisturizer with sunscreen daily 3
Alternative First-Line Options
If triple combination is unavailable or not tolerated:
- Hydroquinone 4% alone (FDA-approved for "bleaching of hyperpigmented skin") combined with tretinoin 0.025-0.1% 1, 5
- Azelaic acid 15-20% is particularly effective for PIH in darker skin types and has lower irritation potential 1, 5
- Kojic acid, arbutin, or licorice extracts as tyrosinase inhibitors for patients avoiding hydroquinone 5
Expected Timeline and Management
- Weeks 0-4: Expect possible mild irritation, peeling, or temporary worsening; this represents skin adjustment 3
- Weeks 6-12: Visible improvement should begin; continue treatment consistently 3, 1
- Week 12+: Reassess response; if inadequate, proceed to combination with procedures 1, 2
Second-Line: Procedural Interventions
Add procedures only after 12 weeks of topical therapy or for recalcitrant cases:
- Chemical peels (glycolic acid, salicylic acid, or trichloroacetic acid) enhance topical penetration and accelerate results 1, 2, 5
- Microneedling combined with topical agents improves delivery and efficacy 1, 2
- Fractional non-ablative lasers or intense pulsed light (IPL) for resistant cases 1, 4
- Q-switched or picosecond lasers target dermal pigment but carry higher risk of worsening PIH in darker skin types 1, 4
Critical caveat: Procedures must be combined with ongoing topical therapy and photoprotection, never used as monotherapy 1, 4
Emerging Oral Therapies
For extensive or refractory melasma:
- Tranexamic acid (oral) shows promising results for melasma 2
- Polypodium leucotomos and glutathione have demonstrated varying efficacy 2
Maintenance Therapy
After achieving clearance, continue tretinoin indefinitely with daily sunscreen to prevent recurrence 3, 1, 4
- Melasma can be controlled and improved but requires ongoing maintenance 1
- PIH can be cured in most cases with proper treatment 1
- Discontinuing treatment typically results in recurrence, especially with sun exposure 4
Critical Pitfalls to Avoid
- Never skip photoprotection: Sun exposure is the primary cause of treatment failure and recurrence 1, 2, 4
- Avoid excessive irritation: Over-washing, harsh scrubbing, or using too much medication worsens hyperpigmentation 3, 5
- Do not use procedures as monotherapy: Always combine with topical agents and photoprotection 1, 4
- Caution with lasers in darker skin: Aggressive laser treatment can paradoxically worsen PIH in skin of color 5, 4
- Start treatment early: Delayed treatment of PIH prolongs resolution time 5
Special Considerations for Darker Skin Types
- Azelaic acid is preferred over hydroquinone in darker skin due to lower risk of irritant contact dermatitis and paradoxical hyperpigmentation 5
- Chemical peels require lower concentrations and shorter contact times in darker skin to prevent worsening 5
- Avoid hydroquinone-induced ochronosis by limiting continuous use and monitoring for blue-gray discoloration 1